SLC6A14 and myocardial infarction: Mechanistically, estrogen-like metabolites from L-EVs modulated the estrogen receptor alpha (ERα)-solute carrier family 6 member 14 (Slc6a14)-Hippo signalling pathway to promote intestinal stem cell function and ultimately protected against MI-induced adverse remodelling.